Clinical updates, including trial initiations, enrollment status and data readouts and publications: Akero, Anokion, Frequency, Ideaya, Incyte, Ionis, Lineage, Neoimmunetech, Novartis, Omeros, Oramed, Precigen, Recordati, Regeneron, Roche, Sojournix.